Did Halma & Marik highlight harms by the COVID spike protein due to virus AND COVID vaccine (mRNA technology based gene injection)? Yes!

by Paul Alexander




One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury.

Biodistribution studies have found significant expression of spikes in other tissues and organs [12],

and researchers have found both vaccine mRNA and spike protein (which is encoded by the vaccine sequence) two months post-administration [14],

and even up to four months post-vaccination [13].

One preprint study of people with SARS-CoV-2 negative post-vaccination Long COVID-19-like symptoms showed spike protein persistence, on average, 105 days post vaccination [19].

Long COVID-19 patients (post SARS-CoV-2 infection) show spike protein persistence up to 15 months [20].

Another study showed spike protein persistence in the gut of long COVID-19 patients, but not in the bloodstream.

Spike proteins can be packaged in exosomes [13],

possibly resulting in inflammation and immune activation [21,22]

in organs and tissues distant from the injection site [13]. Extracellular vesicles are capable of crossing the blood–brain barrier [23],

and LNPs, as well as exosomes, will exchange more readily in small diameter vessels with low flow rates (i.e., capillaries and small vessels) [24]. Importantly, the spike protein seems to additionally impact blood–brain barrier permeability [25,26].’